These findings prompted us to assess whether changes in IL-1β, VEGF, NO metabolite, and pro-inflammatory cytokine including IL-6 and TNF-α production occur in BLM-treated rats following BMDMSC transfer to evaluate the mechanism of the protective effect of BDMSC transfer against ALI/fibrosis. This evidence concerns the gene VEGFA and Bloom syndrome.